F. Serejo

Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.

J. Braz Nogueira, Carlos dos Santos Moreira, F. Serejo, 2015, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

Correlation of Genotypes and Route of Transmission with Histologic Activity and Disease Stage in Chronic Hepatitis C

R. Marinho, F. Ramalho, M. Raimundo, 2004, Digestive Diseases and Sciences.

Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III.

F. Ramalho, M. D. de Moura, F. Serejo, 2001, Digestive diseases and sciences.

The soluble form of HFE protein regulates hephaestin mRNA expression in the duodenum through an endocytosis-dependent mechanism.

P. Faustino, C. Baldaia, J. Ferreira, 2014, Biochimica et biophysica acta.

Oxidative stress in chronic hepatitis C: the effect of interferon therapy and correlation with pathological features.

I. Emerit, J. Freitas, M. D. de Moura, 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

ABCA1 Polymorphism R1587K in Chronic Hepatitis C Is Gender-Specific and Modulates Liver Disease Severity through Its Influence on Cholesterol Metabolism and Liver Function: A Preliminary Study

M. Bicho, J. Ferreira, F. Serejo, 2022, Genes.

1021 GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA (HCC) AND OF ITS TREATMENT WITH SORAFENIB (GIDEON): IMPACT OF LIVER DYSFUNCTION ON SORAFENIB TREATMENT IN EUROPE

B. Daniele, G. Bodoky, A. Croitoru, 2012 .

Clastogenic Factors as Biomarkers of Oxidative Stress in Chronic Hepatitis C

I. Emerit, F. Ramalho, M. Carneiro de Moura, 2000, Digestion.

Clastogenic factors in the plasma of patients with hepatitis C: their possible role at the origin of hepatocarcinoma.

I. Emerit, M. Carneiro de Moura, F. Serejo, 2007, Cancer genetics and cytogenetics.

Oxidative stress in chronic hepatitis C: a preliminary study on the protective effects of antioxidant flavonoids.

I. Emerit, M. Carneiro de Moura, J. Freitas, 2005, Hepato-gastroenterology.

Role of Inflammatory/Immune Response and Cytokine Polymorphisms in the Severity of Chronic Hepatitis C (CHC) before and after Direct Acting Antiviral (DAAs) Treatment

M. Bicho, J. Ferreira, F. Serejo, 2023, International journal of molecular sciences.

Monitoring Waterborne Pathogens in Surface and Drinking Waters. Are Water Treatment Plants (WTPs) Simultaneously Efficient in the Elimination of Enteric Viruses and Fecal Indicator Bacteria (FIB)?

P. Nogueira, Daniel Salvador, C. Neto, 2020, Water.

Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study.

B. Daniele, G. Bodoky, A. Croitoru, 2015, Future oncology.

Interferon improves liver fibrosis in patients with chronic hepatitis C

F. Ramalho, M. Moura, F. Serejo, 2000 .

Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters

M. Bicho, F. Serejo, Joana Ferreira, 2024, Viruses.